USPTO serial 79219522
Serial No. 79219522
Reviewed by CopyMark Law Group
Reg. 5724198Status 707Registered
- Filing date
- Status date
- Registration date
- Apr 16, 2019
- Examiner
- MCMORROW, JANICE LEE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79219522?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Catherine F. Hoffman
Catherine F. Hoffman Baker, Donelson, Bearman, Caldwell & Berkowitz, PC200 East Broward Blvd, Suite 2000Ft. Lauderdale, FL 33301United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Diagnostic preparations for medical, pharmaceutical or veterinary purposes; in-vitro diagnostic preparations for medical or veterinary use; chemical reagents for medical or veterinary purposes; reagents for in-vitro laboratory use for veterinary or medical purposes; reagents for microbiological analysis, in particular for veterinary or medical purposes; genetic and molecular-biological identity tests, in particular comprised of reagents for medical or veterinary purposes; immunoreagents for medical or veterinary purposes; chemical preparations for use in nucleic acids and medical protein analysis, in particular in DNA and RNA; preparations of microorganisms for medical or veterinary purposes; preparations for detecting genetic predispositions for medical or veterinary purposes; preparations for detecting genes for medical or veterinary purposes, in particular mutated genes; bouillons for biological cultures, in particular bacteriological cultures; nutritive substances for microorganisms; serums, in particular antiserums for diagnostic purposes; antibodies for diagnostic purposes; diagnostic biomarker reagents for medical or veterinary purposes; contrasting agents for diagnostic ultrasound imaging ] | SECTION 71 - CANCELLED | — |
| 009 | [ Biochips for research or scientific purposes; biological microscopes; chemistry apparatus and instruments used for mechanical and functional testing of medical device technologies, namely, mass spectrometers; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of inductively coupled plasma torches and atomic emission spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of liquid chromatography separating apparatus and mass spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus, instruments in the nature of gas chromatography separating apparatus and mass spectrometers used together for analysis and testing of medical device technologies; chemistry apparatus and instruments, namely, apparatus and instruments in the nature of Fourier-transform infrared spectrometers, ultraviolet-visible spectrometers, nuclear magnetic resonance spectrometers and mass spectrometers for testing gas, liquids and solids; chemistry apparatus instruments, namely, apparatus and instruments in the nature of flow cytometry analyzers and sorters, real time PCR thermal cyclers, mass cytometry analyzers, and liquid handling robots for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, contaminants, pathogens, allergens, antigens, metabolites, proteins, biologics; DNA microarrays; DNA chips; filter diaphragms for laboratory use; chromatography components in the nature of injectors, columns and apparatus for laboratory use, in particular liquid chromatography injectors, columns and apparatus for laboratory use; laboratory apparatus in the nature of laboratory freezers for cryogenic preservation, pipettes, microplates, microplate readers, microplate spectrophotometers, microplate photometers, microplate washers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for analyzing diseases and genome information for the purposes of performing NGS (Next Generation Sequencing) tests, ELISA (Enzyme-linked Immunosorbent Assay) tests, PCR (Polymerase Chain Reaction) tests and related technologies and methods; laboratory apparatus in the nature of laboratory freezers for cryogenic preservation, pipettes, microplates, microplate readers, microplate spectrophotometers, microplate photometers, microplate washers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for analyzing diseases and genome information, including but not limited to apparatus for the purposes of performing NGS (Next Generation Sequencing) tests, ELISA (Enzyme-linked Immunosorbent Assay) tests, PCR (Polymerase Chain Reaction) tests; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of centrifuges, homogenizers and thermal cyclers (PCR machines) for extracting nucleic acid, DNA, RNA; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of DNA sequencers for sequencing nucleic acid, DNA, RNA; laboratory apparatus in the nature of thermal cyclers (PCR machines) and real time PCR thermal cyclers for sequencing nucleic acid, DNA, RNA; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of thermal cyclers (PCR machines) and real time PCR thermal cyclers for detecting genetic sequences; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of electropheresis systems and spectrophotometers for analyzing proteins; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of mass spectrometers, spectrophotometers and real time PCR thermal cyclers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, contaminants, pathogens, allergens, antigens, metabolites, proteins, biologics; laboratory apparatus for analyzing diseases and genome information, namely, laboratory apparatus in the nature of mass spectrometers, ultraviolet-visible spectrometers, Fourier-transform infrared spectrometers, nuclear magnetic resonance spectrometers, time-of-flight mass spectrometers, isotope ratio mass spectrometers, thermal cyclers (PCR machines), real time PCR thermal cyclers and DNA sequencers for testing foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water for the presence of contaminants; apparatus for laboratories, in particular optical apparatus in the nature of video cameras and interferometers used for mechanical and functional testing of medical device technologies, namely, Prosthetic Heart Valve Testing Systems comprised of a pump, pressure sensors and laboratory tray, Endovascular Prostheses Testing Systems comprised of a pump, pressure sensors and laboratory tray, Pulsatile Pump Systems comprised of a pump, pressure sensors and laboratory tray, Heating Circulator Apparatus in the nature of an electric laboratory bath, Simulated Use Test Systems comprised of a pump, pressure sensors and laboratory tray and Silicone Mock Vessels and Anatomical Models; apparatus for laboratories, in particular optical apparatus, namely, optical inspection apparatus; apparatus for laboratories, in particular optical apparatus, namely, optical sensors, cameras, scanners, collimators, interferometers, monochromators, refractometers, spectrometers, microscopes; separating apparatus in the nature of centrifuges for laboratory use used for mechanical and functional testing of medical device technologies, namely, Prosthetic Heart Valve Testing Systems comprised of a pump, pressure sensors and laboratory tray, Endovascular Prostheses Testing Systems comprised of a pump, pressure sensors and laboratory tray, Pulsatile Pump Systems comprised of a pump, pressure sensors and laboratory tray, Heating Circulator Apparatus in the nature of an electric laboratory bath, Simulated Use Test Systems comprised of a pump, pressure sensors and laboratory tray and Silicone Mock Vessels and Anatomical Models; separating apparatus for laboratory use, namely, laboratory instruments in the nature of gas chromatography separating apparatus and liquid chromatography separating apparatus for the separation of mixtures of chemical compounds; separating apparatus for laboratory use, namely, laboratory centrifuges; chromatography separating apparatus for laboratory use; separating apparatus for laboratory use, namely, pre-packed columns for use in separation and purification ] | SECTION 71 - CANCELLED | — |
| 035 | Business management and business administration, for others | ACTIVE | — |
| 041 | Conducting of training courses and seminars, in particular for imparting knowledge in the field of food hygiene and food legislation | ACTIVE | — |
| 042 | Conducting of analytical, chemical, physicochemical, physical, biochemical, biological, molecular biological, microbiological, enzymatic and sensory tests of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products; product testing in order to check conformity of the declarations and marking of packaging; testing the declarations and marking of packaging for conformity on the packaging itself; testing the accuracy of declarations and marking of packaging by testing the product contained inside said packaging to determine if the product conforms to the declarations and markings on the packaging; conducting quality checking and safety checking on imported goods; product quality checking and testing; testing, analysis and evaluation services of quality standards in foodstuffs, foodstuffs for animals and beverages; testing ingredients and additives in foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products; testing, analysis and evaluation services of quality standards, namely, determining the composition, nutritional values or selected parameters for characterising product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water, in particular of meat and charcuterie, fish and fish products, dairy products, edible fats, bread and bakery products, ices, convenience goods, foodstuffs, confectionery, foodstuffs for animals; testing, analysis and evaluation services of quality standards, namely, determining the composition, nutritional values or selected parameters for testing the observance of legally required limit values or the observance of specification values for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water, in particular of meat and charcuterie, fish and fish products, dairy products, edible fats, bread and bakery products, ices, convenience goods, foodstuffs, confectionery, foodstuffs for animals; testing, analysis and evaluation services relating to the application of standards, in particular good manufacturing practice (GMP) and global food safety initiative standards and other commercial checking standards; consultancy relating to quality control; developing, testing and implementation of quality management systems to support and aid others in controlling product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; developing, testing and implementation of quality management systems for controlling product quality of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; design, development and implementation of quality management and self-inspection systems and HACCP (hazard analysis and critical control points) concepts to support and aid others in controlling product quality for foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; design, development and implementation of quality management and self-inspection systems and HACCP (hazard analysis and critical control points) concepts for controlling product quality of foodstuffs, pharmaceutical products, cosmetics, commodities, foodstuffs for animals, tobacco products, beverages and drinking water; testing, analyzing, procuring of samples and evaluation services for the chemical and microbiological testing of foodstuffs, foodstuffs for animals, beverages, drinking water, pharmaceutical products, cosmetics, commodities and tobacco products to determine the composition, nutritional values or selected parameters for characterizing product quality or for testing the observance of the legally required limit values or the observance of specification values for the aforementioned products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tentamus Group GmbH
- Other trademarks owned by Tentamus Group GmbH
- Other trademarks owned by Tentamus Group GmbH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 18, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 18, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 18, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Aug 12, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 21, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 16, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 27, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 27, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 27, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 27, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 30, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 8, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 8, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 16, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 19, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 19, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 27, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 27, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 29, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 29, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 25, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 9, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 9, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 26, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 11, 2018 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 8, 2018 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Dec 4, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 30, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 30, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 30, 2018 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 30, 2018 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 30, 2018 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| May 31, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 31, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 31, 2018 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 14, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2018 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| May 9, 2018 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Apr 5, 2018 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 1, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 13, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 13, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 3, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 2, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |